Jane Street Group LLC Sells 22,834 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Jane Street Group LLC decreased its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 11.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 171,851 shares of the company's stock after selling 22,834 shares during the quarter. Jane Street Group LLC owned about 0.10% of Option Care Health worth $3,987,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. boosted its holdings in shares of Option Care Health by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company's stock worth $448,118,000 after buying an additional 75,313 shares in the last quarter. Wellington Management Group LLP boosted its stake in Option Care Health by 84.6% during the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after acquiring an additional 8,400,208 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Option Care Health by 17.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock valued at $92,518,000 after purchasing an additional 591,042 shares during the period. Northern Trust Corp boosted its position in shares of Option Care Health by 11.8% during the 4th quarter. Northern Trust Corp now owns 2,626,478 shares of the company's stock worth $60,934,000 after purchasing an additional 278,158 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of Option Care Health in the 4th quarter valued at about $60,219,000. 98.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. JPMorgan Chase & Co. raised their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. JMP Securities reissued a "market outperform" rating and set a $36.00 price objective on shares of Option Care Health in a report on Tuesday, April 22nd. Barrington Research restated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research note on Wednesday, April 30th. Finally, Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and increased their price objective for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $35.50.

Option Care Health Stock Performance

Shares of OPCH stock traded up $0.23 during trading hours on Wednesday, hitting $31.79. 1,502,212 shares of the company were exchanged, compared to its average volume of 1,853,312. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $5.21 billion, a price-to-earnings ratio of 26.71, a P/E/G ratio of 2.30 and a beta of 0.76. The firm has a fifty day simple moving average of $33.13 and a 200 day simple moving average of $28.92. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.04. The firm had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The business's revenue was up 16.3% on a year-over-year basis. During the same period in the previous year, the company posted $0.26 earnings per share. Research analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Insider Activity at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. This trade represents a 40.80% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.